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The Centers for Disease Control and Prevention(CDC) and the Agency for Healthcare Research
and Quality (AHRQ) have studied and incorporated
different measures of health-related quality of life
(HRQOL) in surveys of the US general population.
These measures include slightly different concepts/
constructs that are viewed to ‘‘best represent’’ health
and may be administered with relative ease.1, 2 The
Healthy Days Measures are a set of non-preference-
based HRQOL survey measures developed by the
CDC and administered in the Behavioral Risk Factor
Surveillance System (BRFSS) that were designed to
be brief and valid.1, 3 By contrast, the EQ-5D, an inter-
nationally developed preference-based measure,4, 5
was used by the AHRQ in the Medical Expenditure
Panel Survey (MEPS) and has been shown to be valid
and reliable.6, 7
Many investigators have proposed estimating
preference-based scores from non-preference-based
measures.8–12 For example, with the inclusion of
both the SF-12 and EQ-5D in the MEPS from 2000 to
2003, algorithms have been developed that may con-
vert the SF-12 subscale scores to an EQ-5D index
score using multiple regressions.8, 9, 13, 14 The resul-
tant scores can be used to measure quality-adjusted
life years (QALYs) in cost-utility analyses.
The CDC has incorporated the Healthy Days Mea-
sures as part of the BRFSS since 19931, 2, 15 and in
the National Health and Nutrition Examination Sur-
vey (NHANES) since 2000. These measures define
HRQOL as ‘‘perceived physical and mental health
over time’’ and ask respondents about their recent
number of poor health days. Unlike the MEPS, the
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METHODOLOGY FOR HEALTH STATE VALUATIONS
BRFSS was designed to provide reliable state-level
estimates of healthy days and estimates for some sub-
state areas,16 or detailed annual and monthly esti-
mates for large geographic areas.1 Healthy Days Mea-
sures identify known or suspected groups with unmet
health-related needs, including persons of low socioe-
conomic status or with disabilities.1 Additionally,
the Healthy Days Measures and EQ-5D scores were
designed to measure HRQOL using the same level of
measurement (ratio scale).1, 3, 17 Thus, estimation of
the EQ-5D scores from the Healthy Days Measures can
provide data for cost-utility analyses and can capture
the advantages and disadvantages of both measures.
However, developing an estimation equation of
EQ-5D scores from the Healthy Days Measures cannot
be done directly8, 9 because of the lack of population-
based data that includes responses to both HRQOL
measures for the same respondents. This study pro-
posed an alternative method to estimate EQ-5D scores
from the Healthy Days Measures indirectly. In parti-
cular, this study estimated EQ-5D scores from the
number of overall healthy days for subgroups of per-
sons in any given age category and for any given age
and self-rated heath. The validity of estimates was
examined by ecological analyses of mean scores in
different population subgroups and by simulations.
MATERIALS AND METHODS
Data Sources
Data came from 2 representative samples of the
US adult population: the 2000–2002 BRFSS and the
2000–2002 MEPS. The BRFSS is an ongoing annual
state-based telephone interview survey using the
random-digit dial method to generate population-
based representative samples of noninstitutionalized
civilian adult residents from each of the 50 states
and the District of Columbia.15, 18
The BRFSS included the Healthy Days Measures
to track population HRQOL. Respondents were asked
to report the number of days in the past 30 days when
their physical health was not good (physically
unhealthy days) and when their mental health was
not good (mentally unhealthy days). The overall
healthy days were calculated by subtracting respon-
dents’ physically unhealthy and mentally unhealthy
days from 30 days, with a logical minimum of zero
healthy days.3 From 2000 to 2002, 626,119 adults
responded to the BRFSS; however, respondents from
the 29 states that did not answer all the Healthy Days
questions in 2002 were excluded from the analysis,
leaving a total sample size of 489,624.
The MEPS, a representative survey of the US non-
institutionalized, civilian population, provided the
data source for the EQ-5D.19, 20 The household com-
ponent of the MEPS contains detailed data about so-
ciodemographic characteristics and selected chronic
conditions. Since 2000 the MEPS distributed a self-
administrated paper questionnaire to adult partici-
pants that included the EQ-5D from 2000 until
2003.21
The EQ-5D comprises a descriptive system and
a visual analog scale (EQ VAS) intended to assess
health today. The descriptive system enables res-
pondents to classify their health on 1 of 3 levels
according to 5 dimensions: mobility, self-care, usual
activities, pain/discomfort, and anxiety/depression.
The data may be used to represent a profile of health
status or converted into a single summary index
(EQ-5D index) by applying scores from a valuation
set.4 The scoring algorithm used for this research is
based on preferences from the US general popula-
tion using the time tradeoff (TTO) method.22 The
EQ VAS is anchored at 100 (best imaginable health)
and 0 (worst imaginable health) and captures a self-
rating of health status.4 Although 60,653 adults
were in the 2000–2002 MEPS, only the responses of
the 53,666 adults who completed questions in the
self-administrated paper questionnaire are analyzed
here.
Estimating EQ-5D Scores from Healthy Days
The estimates were obtained by matching the
cumulative distributions of the 2 HRQOL measures.
First, the cumulative distributions of the healthy days
and the EQ-5D scores were estimated separately from
the BRFSS and MEPS, respectively. The cumulative
distribution is the percentage of the population whose
scores were less than or equal to a given value or
the percentile. Then, the 2 cumulative distributions
were merged by matching their percentiles. The mer-
ged data gave the equivalent scores of the 2 measures
at the same percentile and thus provided the esti-
mated EQ-5D scores for any given number of healthy
days. For example, approximately 34.7% of US adults
reported having 25 or fewer overall healthy days dur-
ing the past 30 days. Because the estimated percen-
tage of respondents who scored 0.815 or less in EQ-
5D index was 34.7%, too, the estimated EQ-5D index
score for persons with 25 healthy days was 0.815. The
underlying assumption of the proposed method is
that the MEPS and BRFSS are roughly comparable
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surveys that provide approximately the same esti-
mated mean score of HRQOL for the community resi-
dent adults if the same HRQOL measure was used.
To obtain a reliable and ‘‘smooth’’ estimation of
the cumulative distributions, this study used the
nonparametric density estimation method based on
data smoothing.23 The estimation also was adjusted
for the differences in sampling weights and post-
stratification of the BRFSS and MEPS to eliminate
differences in bias of 2 data sets. Because age is
strongly related to EQ-5D but weakly related to
healthy days,3, 17 age must be incorporated as an
additional predicting variable. To do this, the above
analysis was done separately in 5 age categories
(18–24, 25–44, 45–64, 65–74, and 75 years and over)
to provide estimated EQ-5D scores based on the
number of healthy days and age categories. Because
the self-rated general health question is included in
many health surveys and frequently is used to mea-
sure population health status,24, 25 we also provided
the estimated EQ-5D scores based on the number of
healthy days, age categories, and self-rated general
health using the above method with the logical
requirement that EQ-5D scores increase with the
improvement of self-rated health status from the low-
est level (‘‘poor’’) to the highest level (‘‘excellent’’).
Evaluation of Estimations
The validity of estimates was evaluated in 2 ways.
First, we compared the mean estimated EQ-5D scores
from the BRFSS to the mean observed EQ-5D scores
from the MEPS according to the following sociodemo-
graphic subgroups and health characteristics: age,
gender, race/ethnicity, educational attainment, cate-
gory of body mass index (BMI), self-rated health, pre-
sence and degree of activity limitations, and the
presence of selected chronic diseases (asthma, hyper-
tension, diabetes, heart disease, or stroke).
Second, simulations were conducted to compare
the performance of estimation using the proposed
method and the commonly used regression meth-
od.8, 9 The EQ-5D scores of respondents in the
BRFSS data set were generated based on respon-
dent’s age, race/ethnicity, gender, education, self-
rated health, and activity limitation level and a
Gauss random term. The equation to generate EQ-5D
scores was estimated from the MEPS. We then
estimated respondents’ EQ-5D scores from their
responses of healthy days and age category using the
2 estimation methods separately and compared some
goodness-of-fit statistics between these 2 methods.
RESULTS
First, we examined the comparability of MEPS
and BRFSS data by comparing the population distri-
bution of some demographic and health variables in
the 2 data sets (Table 1). The difference of estimated
proportions between the 2 data sources is less than
3 percentage points in the 3 demographic variables
and the activity limitation variable. Compared with
BRFSS respondents, MEPS respondents were less
likely to report ‘‘excellent’’ and ‘‘poor’’ health, but
the difference is less than 5 percentage points.
Table 2 presents the estimated EQ-5D index and
EQ VAS scores based on respondents’ age category
and the number of healthy days. For example, the
estimated EQ-5D index and EQ VAS are 0.842 and
83.4, respectively, for a 30-year-old person who
reports 27 overall healthy days. Similarly, we also
estimated EQ-5D index and EQ VAS scores from the
number of healthy days for any adult in a given age
category and level of self-reported health status.
(These data are not shown but are available from the
authors upon request.) For example, the estimated
EQ-5D index is 0.841 for a 30-year-old person who
reports 27 overall healthy days and ‘‘good’’ health.
Because individual level cross-validation of esti-
mates was impossible due to the lack of data, valid-
ity of estimation was evaluated at the community
level. The estimated EQ-5D scores were evaluated by
comparing the mean estimated EQ-5D scores from
the BRFSS to the mean observed EQ-5D scores from
the MEPS in subgroups according to selected socio-
demographic variables and health conditions. Table
3 presents the results. In the table, the estimates are
based on model 1, using age and healthy days to esti-
mate EQ-5D scores, as well as model 2, using age,
self-rated health status, and healthy days to estimate
EQ-5D index scores. The overall means of estimated
EQ-5D index scores based on the 2 models were
0.866 and 0.872, respectively, which were very close
to the mean of the actual score (0.871). The overall
means of estimated EQ VAS scores from both models
(80.8 and 80.7, respectively) also were very close to
the mean observed score (80.5).
When examined by subgroups of sociodemo-
graphic and health-related variables, the mean pre-
dicted EQ-5D scores (both EQ-5D Index and EQ
VAS) based on both models and the mean actual
scores varied similarly according to subgroups for
all examined variables. The data showed a good
match of mean estimated and observed scores. The
differences were particularly small according to age,
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gender, race/ethnicity, educational attainment, cate-
gory of BMI, and the presence of any disease
(< 5%). Self-rated health status and activity limita-
tion affected estimated and observed mean EQ-5D
scores in a similar manner. The mean estimated and
observed scores decreased with worsening category
of self-rated health and impairment of activity lim-
itation. However, the differences between the esti-
mated scores using model 1 and observed scores
were among the biggest for persons who reported
‘‘fair’’ or ‘‘poor’’ health, for persons who had impair-
ments of instrumental activities of daily living
(IADL) or activities of daily living (ADL), and for
persons who had reported a stroke. By adding self-
rated health in the model (model 2), the estimated
scores became much closer to the observed scores,
particularly among respondents who reported
‘‘excellent,’’ ‘‘fair,’’ and ‘‘poor’’ health. However,
even after adding self-rated health in the model, the
magnitude of difference between estimated scores
and observed scores was greatest for the most
impaired health states—that is, fair and poor self-
rated health, impairments in IADL or ADL, and per-
sons who had reported a stroke.
We also applied a simulation study to compare
the performance of the alternative method to the
commonly used regression method. By changing the
variance of the random term, we generated several
sets of EQ-5D scores at different levels of association
with healthy days. Figure 1 presents plots of R2 and
root of mean square error (RMSE) against correlation
coefficients between healthy days and simulated EQ-
5D scores. As expected, the R2 of estimations from
both methods increased as the correlation coefficient
increased and the RMSE of both methods decreased
as the correlation coefficient increased. Also, as
expected, the R2 values of alternative estimates were
9–12% lower than that of regression estimates and
the RMSEs of alternative estimates were 0.012–0.015
points higher than that of regression estimates.
Table 1 Comparison of Estimated Proportion by Some Demographic
and Health Variables from the 2000–02 BRFSS and MEPS
BRFSS, % MEPS, % Difference, %
Age
18–24 12.9 12.0 0.9
25–44 39.7 40.5 0.8
45–64 30.4 31.7 1.3
65–74 10.2 8.9 1.3
75+ 6.9 6.9 0.0
Sex
Male 48.2 45.2 3.0
Female 51.8 54.8 3.0
Race/ethnicity
White, non-Hispanic 72.8 73.6 0.8
Black, non-Hispanic 9.6 11.2 1.6
Hispanic 13.4 11.2 2.2
Asian/Pacific Islander 3.2 3.4 0.2
AI/AN 1.1 0.6 0.4
Self-rated health
Excellent 22.0 17.7 4.3
Very good 33.1 37.7 4.6
Good 29.4 31.1 1.7
Fair 11.4 11.1 0.3
Poor 4.1 2.5 1.7
Activity limitation (AL)
No AL 83.2 85.3 2.1
AL, no help needed 13.9 12.1 1.8
IADL, no ADL 1.9 1.5 0.4
ADL 0.9 1.1 0.2
Note: BRFSS = Behavioral Risk Factor Surveillance System; MEPS = Medical Expenditure Panel Survey; AI/AN = American Indian/Alaskan Native;
IADL = instrumental activities of daily living; ADL = activities of daily living.
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DISCUSSION
Using Healthy Days Measures to track population
HRQOL has become increasingly common because
it provides a simple yet valid measurement of popu-
lation overall health.1;3 Since no representative data
set includes both EQ-5D scores and the number of
healthy days, we obtained the equivalent EQ-5D
score of a given number of healthy days at the same
percentile indirectly. Because Healthy Days Mea-
sures have been used in the BRFSS since 1993 and
the NHANES since 2000, translating the number of
healthy days to a preference-based measure would
be applicable in certain circumstances. We should
take advantage of the BRFSS and NHANES data and
conduct analyses that previously were unable to be
done. Specifically, our derived EQ-5D scores might
be particularly useful when examining changes in
HRQOL over time (with regard to long term time
trend and seasonal variations) as well as HRQOL at
the state and community levels and for small socio-
demographic subgroups.
Such a method that compares the distributions of
different measures across populations has been used
in studies of the impact of inequalities of wealth
on health26 and in comparing different SF-36 scor-
ing methods in the US and UK population.27 The
estimated EQ-5D scores based on the proposed
method are unique and unbiased with the 2 HRQOL
measures monotonically increasing (i.e., increasing
healthy days must result in increasing estimated
EQ-5D scores). Also, all estimated EQ-5D scores
from regressions must satisfy the requirement of a
matching cumulative distribution with the healthy
Table 2 Estimated EQ-5D Index and EQ VAS Scores from the Number of Healthy Days by Age Category
18–24 Years 25–44 Years 45–64 Years 65–74 Years 75+ Years
Healthy
Days EQ-5D EQ VAS EQ-5D EQ VAS EQ-5D EQ VAS EQ-5D EQ VAS EQ-5D EQ VAS
30 0.999 97.2 0.998 94.3 0.968 91.8 0.905 88.7 0.883 85.8
29 0.998 93.6 0.995 89.6 0.834 84.3 0.823 79.6 0.811 75.1
28 0.997 90.5 0.949 86.5 0.827 80.5 0.817 77.4 0.806 73.3
27 0.994 89.6 0.842 83.4 0.823 79.7 0.809 74.6 0.795 70.2
26 0.992 88.0 0.833 80.4 0.818 79.1 0.802 71.6 0.782 69.8
25 0.914 85.1 0.827 79.8 0.809 75.5 0.796 70.2 0.778 69.4
24 0.843 84.1 0.824 79.4 0.803 74.5 0.784 69.8 0.776 67.2
23 0.839 80.9 0.821 77.2 0.800 71.5 0.779 69.5 0.773 64.3
22 0.832 80.0 0.816 75.1 0.797 70.2 0.776 68.2 0.770 61.0
21 0.829 79.8 0.811 74.8 0.795 70.0 0.776 66.0 0.769 60.6
20 0.826 79.2 0.804 73.1 0.787 69.7 0.773 64.1 0.764 60.2
19 0.824 77.0 0.801 70.5 0.778 69.4 0.770 61.4 0.758 59.9
18 0.823 75.6 0.800 70.3 0.777 69.2 0.769 60.9 0.756 59.8
17 0.821 75.2 0.799 70.1 0.776 68.5 0.768 60.6 0.753 59.8
16 0.817 74.7 0.798 69.9 0.773 65.5 0.765 60.2 0.716 59.5
15 0.805 71.3 0.793 69.2 0.767 61.5 0.740 59.6 0.708 55.7
14 0.800 70.0 0.781 66.0 0.761 60.0 0.711 58.7 0.706 51.5
13 0.799 69.8 0.776 65.1 0.759 59.9 0.711 55.9 0.706 51.1
12 0.797 69.6 0.773 64.6 0.757 59.8 0.710 55.3 0.705 50.9
11 0.797 69.4 0.771 63.7 0.755 59.7 0.710 55.0 0.705 50.8
10 0.794 66.9 0.767 60.7 0.717 58.4 0.708 53.2 0.704 50.5
9 0.789 64.7 0.763 60.0 0.709 55.1 0.707 50.9 0.702 50.2
8 0.779 63.4 0.760 59.8 0.708 54.2 0.706 50.6 0.701 50.2
7 0.773 61.0 0.758 59.7 0.708 52.4 0.706 50.5 0.701 50.2
6 0.771 60.6 0.754 59.6 0.707 51.6 0.706 50.5 0.700 50.1
5 0.768 60.1 0.716 59.1 0.706 50.8 0.705 50.4 0.699 50.1
4 0.766 59.9 0.710 56.1 0.705 50.5 0.705 50.3 0.695 50.0
3 0.765 59.8 0.709 55.4 0.705 50.4 0.705 50.2 0.694 50.0
2 0.763 59.6 0.708 54.3 0.704 50.3 0.704 50.2 0.692 50.0
1 0.760 59.0 0.706 51.9 0.704 50.2 0.703 50.2 0.689 50.0
0 0.528 44.4 0.479 39.8 0.464 38.6 0.453 37.4 0.441 37.2
Note: EQ-5D = EuroQol EQ-5D; EQ VAS = EQ visual analog scale.
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Table 3 Comparing Observed EQ-5D Scores to Estimated EQ-5D Scores
by Sociodemographic and Health Characteristics
EQ-5D Index EQ VAS
Estimated (BRFSS) Estimated (BRFSS)
Observed (MEPS) Model 1 Model 2 Observed (MEPS) Model 1 Model 2
Total 0.871 0.866 0.872 80.5 80.8 80.7
Age, y
18–24 0.923 0.919 0.920 85.9 86.1 86.0
25–44 0.899 0.893 0.899 82.7 83.1 83.1
45–64 0.848 0.843 0.849 78.7 78.7 78.7
65–74 0.819 0.816 0.829 75.9 76.7 76.1
75+ 0.782 0.782 0.787 71.7 72.3 71.5
Sexa
Male 0.884 0.881 0.885 81.4 82.5 81.9
Female 0.860 0.851 0.859 79.6 79.1 79.3
Race/ethnicityb
White, non-Hispanic 0.872 0.867 0.875 80.8 80.8 81.3
Black, non-Hispanic 0.854 0.859 0.859 79.1 80.0 78.8
Hispanic 0.863 0.859 0.853 78.8 80.0 77.5
Asian/PI 0.901 0.898 0.900 80.6 84.4 83.7
AI/AN 0.802 0.825 0.828 75.4 76.0 75.3
Educationb
<High school 0.825 0.831 0.822 74.9 76.8 73.6
High school or GED 0.859 0.860 0.863 79.9 80.1 79.4
>High school 0.893 0.876 0.887 82.6 81.9 82.7
BMI categoriesb
< 18.5 0.837 0.834 0.836 74.2 77.3 76.6
18.5–25 0.888 0.874 0.884 82.4 81.6 82.3
25–30 0.876 0.870 0.876 81.3 81.3 81.1
30–35 0.850 0.852 0.853 78.1 79.2 78.1
35+ 0.814 0.813 0.809 74.0 74.9 72.7
Self-rated healthb
Excellent 0.955 0.919 0.960 93.1 86.8 92.2
Very good 0.913 0.893 0.916 86.5 83.9 86.7
Good 0.852 0.866 0.851 76.7 80.8 77.4
Fair 0.729 0.770 0.742 59.8 69.8 61.8
Poor 0.511 0.589 0.551 39.2 50.9 41.9
Activity limitation (AL)b
No AL 0.899 0.890 0.898 83.3 83.5 83.7
AL, no help needed 0.727 0.749 0.754 66.0 67.8 66.9
IADL 0.581 0.658 0.663 53.5 58.0 56.3
ADL 0.485 0.631 0.631 47.8 55.3 53.0
Diseaseb
None 0.891 0.882 0.894 83.1 82.6 83.4
Any diseases 0.829 0.818 0.816 75.5 75.5 73.8
Asthma 0.823 0.800 0.801 75.0 73.4 72.2
Hypertension 0.813 0.829 0.825 73.9 76.6 74.5
Diabetes 0.793 0.797 0.786 69.8 73.2 69.4
Heart disease 0.745 0.766 0.759 64.7 69.9 66.7
Stroke 0.699 0.743 0.738 60.9 67.3 64.3
Note: EQ-5D = EuroQol EQ-5D; EQ VAS = EQ visual analog scale; MEPS = Medical Expenditure Panel Survey; BRFSS = Behavioral Risk Factor Sur-
veillance System; PI = Pacific Islander; AI/AN = American Indian/Alaskan Native; GED = General Educational Development; BMI = body mass
index; IADL = instrumental activities of daily living; ADL = activities of daily living. Model 1: estimation variables include age and healthy days;
model 2: estimation variables include age, self-rated health, and healthy days.
a. Adjusted for age.
b. Adjusted for age and sex.
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days because the estimation equation should be a
monotonic increase.
The proposed method works only when the expla-
natory variable and dependent variable have a strong
monotonic relationship. This is the case for the
Healthy Days and EQ-5D because both scores were
designed to measure the same respondents’ charac-
teristic (i.e., HRQOL) using a similar ratio scale.3, 28
The number of healthy days can be used to estimate
the proportion of time each respondent lived with-
out any impairment or illness based on his or her
reported number of unhealthy days. Similarly, the
EQ-5D index uses the TTO rating of current health
and quantifies the utility of a health state by the
equivalent percentage of expected life that people
are willing to trade for being free from illness.2, 4
Although estimates based on the proposed
method usually have a larger RMSE and smaller R2
than regression estimates because the least square
method-based regression estimates had a minimum
RMSE and maximum R2, the simulation study
showed that the proposed method performed well.
The alternative estimates were about 10% worse
than the regression estimates differences in terms of
R2 values and such a difference was acceptable con-
sidering the lack of data for direct model fitting.
We compared group means because mean scores
of estimated and observed EQ-5D scores in particu-
lar population subgroups should be comparable,
even if data were from different sources.26, 27 Such
comparisons are important because there has been
increasing interest in using the EQ-5D for popula-
tion health assessment and indicators for commu-
nity health.5, 27, 29 Although the descriptive and
ecological nature of the study imposes some limita-
tions, such a comparison of mean of observed and
estimated EQ-5D scores at the community level can
determine whether the estimated EQ-5D can be used
for community health indicators.30
The evaluation study demonstrated that esti-
mated EQ-5D scores matched well with the actual
EQ-5D scores with regard to community averages in
the vast majority of examined subgroups of a rep-
resentative sample of the US noninstitutionalized
adult population. The exceptions occurred for the
most impaired health states where the model over-
predicted the actual mean scores and the magnitude
of this difference would be considered to be clini-
cally important.31, 32 However, the overestimation of
the lowest score has been explicitly noted in the
estimation of preference-based health measure from
SF-3610 and always happens for any model-based
estimates due to regression toward the mean. The re-
sults also conformed to the patterns of scores accor-
ding to a number of sociodemographic and clinical
variables in the published literature1, 3, 33, 34
Several limitations are present in the proposed esti-
mation method. First, the 2 measures differed with
regard to modes of administration and recall periods
(i.e., Healthy Days was administered over the tele-
phone and measured health over the past 30 days and
the EQ-5D was administered through the mail and
measured health ‘‘today’’). The difference in recall
period may make less of a difference in assessing
population health than in the clinical setting where
health might change according to the nature of the
visit or intervention.35 Second, the method requires
use of only 1 explanatory variable and, therefore, only
can estimate EQ-5D scores using overall healthy days
as opposed to both physical and mental unhealthy
days. Including additional explanatory variables such
as age and self-rated general health entails relying
upon data stratification, requiring enough respon-
dents in each subgroup of stratification. Third, both
the Healthy Days Measures and the EQ-5D have been
noted to have a ceiling effect that may occur when
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Figure 1 Comparison of regression method and alternative
method using simulation.
METHODOLOGY FOR HEALTH STATE VALUATIONS 497
METHODOLOGY / ESTIMATING EQ-5D SCORE FROM HEALTHY DAYS
quality of estimated scores cannot be evaluated using
some model fitting statistics such as R2 and RMSE,
and therefore, we have to rely on simulations to calcu-
late model-fitting statistics.
This study provides preliminary results of esti-
mating EQ-5D from healthy days at this point in
time, given that, to date, no single HRQOL measure
has been incorporated into every national health sur-
vey. For example, the Healthy Days Measures have
been included in the BRFSS and NHANES whereas
the SF-12 has been included in the MEPS since 2000
and the EQ-5D was included in the MEPS from 2000
to 2003. By contrast, the National Health Interview
Survey (NHIS) contains a single question on self-
reported health. The estimates of EQ-5D scores from
the number of overall healthy days had acceptable
validity (unbiased, consistent, and valid for tracking
community mean scores of EQ-5D). However, even
when done well, the indirect method and ecologic
validation are not definitive.
Developing the best estimation equation may
be possible in the future with the release of a
population-based representative data set that inc-
ludes both measures and, ideally, would be admi-
nistered longitudinally. If a direct head-to-head
comparison of the Healthy Days Measures and EQ-
5D cannot be conducted, focusing on subpopula-
tions with a greater magnitude of difference between
estimated and observed EQ-5D scores—that is,
groups in the most impaired health states—would
provide useful information for future research and
policy planning.
The Healthy Days Measures are particularly use-
ful to track health time, especially in small sub-
groups with unmet health needs, and facilitate
monitoring of Healthy People 2010 goals and com-
parisons at the national, state, and community
levels. The integration and synthesis of 2 different
nationally representative surveys would expand the
data available for QALY-based cost-utility analyses
and burden of disease studies. In addition, the avail-
ability of these preliminary scores could reduce
respondent burden in primary data collection and
provide an additional use for the BRFSS data.
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